Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
NCT04883346
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
NIH
Sponsor class
Conditions
Obesity
Status Post Sleeve Gastrectomy
Interventions
DRUG:
Liraglutide
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)